Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
GRI Bio Inc.
GRICurrent price
0.64 USD
-0.061 USD (-8.71%)
Last closed
0.69 USD
Company
www.alpsfunds.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 849 002 USD
Yield for 12 month
-99.30 %
1Y
3Y
5Y
10Y
15Y
GRI
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase II clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 for the treatment of primary sclerosing cholangitis, and GRI-0729, which are in pre-clinical development. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California. Address: 2223 Avenida de la Playa, LA Jolla, CA, United States, 92037
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12 USDP/E ratio
0.0135Dividend Yield
–Current Year
+21 767 000 USD
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
+10 841 000 USD
Last Year
-206 000 USD
Current Quarter
-1 000 USD
Last Quarter
-1 000 USD
Key Figures GRI
1 year
3 years
5 years
10 years
EBITDA
-8 363 000 USD
Operating Margin TTM
PE Ratio
0.0135
Return On Assets TTM
-82.53 %
PEG Ratio
–
Return On Equity TTM
-189.06 %
Wall Street Target Price
12 USD
Revenue TTM
–
Book Value
5.21 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
57.07 USD
Diluted Eps TTM
57.07 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GRI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GRI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:13
Payout Ratio
–
Last Split Date
18.06.2024
Dividend Date
–
Stock Valuation GRI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.0135
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
–
Price Book MRQ
0.6037
Financials GRI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GRI
For 52 weeks
0.3 USD
106.29 USD
50 Day MA
0.62 USD
Shares Short Prior Month
225 823
200 Day MA
4.33 USD
Short Ratio
0.1
Shares Short
924 631
Short Percent
25.11 %
BeatStart